Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Comparison of the Effect of Lung-protective Ventilation on Optic Nerve Sheath Diameter in Obese and Non-obese Patients

9 de noviembre de 2026 actualizado por: Gulay ERDOGAN KAYHAN, Eskisehir Osmangazi University

Comparison of the Effect of Recruitment Maneuver and Individualized Positive End-expiratory Pressure on Optic Nerve Sheath Diameter in Obese and Non-obese Patients Undergoing Laparoscopic Surgery

The gol of this prospective observational study is to evaluate the effect of recruitment maneuvers-employed as part of an intraoperative lung-protective ventilation strategy-and individualized positive end-expiratory pressure (PEEP) on intracranial pressure, as assessed by measuring the optic nerve sheath diameter, in both obese and non-obese patients undergoing laparoscopic surgery.

Descripción general del estudio

Estado

Aún no reclutando

Condiciones

Intervención / Tratamiento

Descripción detallada

Laparoscopy is widely used due to its advantages, such as less blood loss, reduced postoperative pain, and faster recovery. However, pneumoperitoneum increases thoracoabdominal pressure, which decreases venous drainage from the brain and increases cerebral blood flow and intracranial pressure (ICP). The optic nerve sheath diameter (ONSD) measurement via ultrasound is a non-invasive and reliable method for assessing ICP.

The prevalence of obesity has increased substantially over recent decades, accompanied by a growing number of obese patients undergoing laparoscopic surgery. Obesity is associated with increased intra-abdominal pressure, which may contribute to an increase in ONSD. Furthermore, the additional rise in intra-abdominal pressure induced by pneumoperitoneum may exacerbate these effects, potentially placing obese patients at greater risk of alterations in cerebral haemodynamics during laparoscopic procedures.

Atelectasis occurs in roughly 90% of all patients undergoing general anaesthesia and can persist for weeks after operation. Intraoperative lung-protective ventilation has been recommended to reduce postoperative pulmonary complications after abdominal and/or laparoscopic surgery and also in obese patients. Decreasing compliance caused by surgical/ anaesthesia factors (i.e. pneumoperitoneum, positioning, and circuit disconnect) should be treated by appropriate interventions. Individualised PEEP and alveolar recruitment manoeuvres can prevent and reverse alveolar collapse, respectively.

However, the effects of these interventions on cerebral haemodynamics, particularly ICP as assessed indirectly by ONSD measurement, remain insufficiently understood in obese and non-obese patients undergoing laparoscopic surgery.

The gol of this prospective observational study is to evaluate the effect of recruitment maneuvers and individualized PEEP- as part of intraoperative lung-protective ventilation strategy- on intracranial pressure, as assessed by measuring the optic nerve sheath diameter (ONSD), in both obese and non-obese patients undergoing laparoscopic surgery.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

70

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Gulay Erdogan Kayhan, Prof. Dr.
  • Número de teléfono: 905332560011
  • Correo electrónico: drgulayer@yahoo.com

Copia de seguridad de contactos de estudio

  • Nombre: Muhammed Alpaslan Uludag, Research Assistant, MD
  • Correo electrónico: muho.78@live.com

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

25 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Patients over 25 years of age
  • American Soc,ety of Anesthesiology (ASA) status I-III
  • Scheduled to undergo laparoscopic abdominal surgery
  • With an expected pneumoperitoneum duration of ≥1 hour

Exclusion Criteria:

  • Patients with ocular disease
  • Patients who have undergone cranial or ocular surgery
  • Patients with a history of laparotomy
  • Individuals with bullous lung disease
  • Patients with uncontrolled chronic obstructive lung disease
  • Patients with hemodynamic instability or decompensated heart failure
  • Patients who require conversion to an open surgical procedure for any reason

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Diagnóstico
  • Asignación: No aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Otro: Group O

Obese patients with BMI ≥ 30 kg/m²

Following intubation and desufflation, an incremental alveolar recruitment maneuver (ARM) will be performed, in which the driving pressure is kept constant while the PEEP value is increased in a stepwise manner. The ARM will be performed in pressure control mode, maintaining pressure at a steady driving pressure with increments in PEEP until a peak pressure is achieved (35-40 cmH2) with a preestablished maximum PEEP. This will be maintained long enough to reopen the alveoli (5---10 breaths), and then pressure is reduced in a stepwise manner until the ideal PEEP is achieved (this being the PEEP level that produces the best Cdyn at the lowest driving pressure for a particular tidal volume setting)

ONSD will be measured at a standard level of 3 mm behind using a lineer ultrasound transducer. The measurements will be performed by an anesthesiologist experienced in ONSD measurement. The eyes will be covered with drapes; subsequently, using an ultrasound-compatible gel, measurements of both of the patient's eyes will be taken in a transverse and a sagittal plane. The mean of these measurements will then be calculated to determine the ONSD value.

Otro: Group N

Non-obese patients

Following intubation and desufflation, an incremental alveolar recruitment maneuver (ARM) will be performed, in which the driving pressure is kept constant while the PEEP value is increased in a stepwise manner. The ARM will be performed in pressure control mode, maintaining pressure at a steady driving pressure with increments in PEEP until a peak pressure is achieved (35-40 cmH2) with a preestablished maximum PEEP. This will be maintained long enough to reopen the alveoli (5---10 breaths), and then pressure is reduced in a stepwise manner until the ideal PEEP is achieved (this being the PEEP level that produces the best Cdyn at the lowest driving pressure for a particular tidal volume setting)

ONSD will be measured at a standard level of 3 mm behind using a lineer ultrasound transducer. The measurements will be performed by an anesthesiologist experienced in ONSD measurement. The eyes will be covered with drapes; subsequently, using an ultrasound-compatible gel, measurements of both of the patient's eyes will be taken in a transverse and a sagittal plane. The mean of these measurements will then be calculated to determine the ONSD value.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Optic nerve sheath diameter (ONSD)
Periodo de tiempo: Perioperative/Periprocedural (t0-after anesthesia induction and entubation)

Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound

Perioperative/Periprocedural (t0-after anesthesia induction and entubation)
Optic nerve sheath diameter (ONSD)
Periodo de tiempo: Perioperative/Periprocedural (t1- following the recruitment maneuver and the adjustment of the individualized PEEP value)

Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound

Perioperative/Periprocedural (t1- following the recruitment maneuver and the adjustment of the individualized PEEP value)
Optic nerve sheath diameter (ONSD)
Periodo de tiempo: Perioperative/Periprocedural (t2- at the 30th minute of pneumoperitoneum)

Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound

Perioperative/Periprocedural (t2- at the 30th minute of pneumoperitoneum)
Optic nerve sheath diameter (ONSD)
Periodo de tiempo: Perioperative/Periprocedural (t3 - after desufflation)

Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound

Perioperative/Periprocedural (t3 - after desufflation)
Optic nerve sheath diameter (ONSD)
Periodo de tiempo: Perioperative/Periprocedural (t4- following a subsequent recruitment maneuver)

Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound

Perioperative/Periprocedural (t4- following a subsequent recruitment maneuver)
Optic nerve sheath diameter (ONSD)
Periodo de tiempo: Perioperative/Periprocedural (t5- at the 30th minute in the recovery room)

Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound

Perioperative/Periprocedural (t5- at the 30th minute in the recovery room)

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
MAP
Periodo de tiempo: Perioperative (Noninvasive mean arterial pressure will be recorded at the times when ONSD measurement is performed)

Noninvasive mean arterial pressure (mmHg)

Perioperative (Noninvasive mean arterial pressure will be recorded at the times when ONSD measurement is performed)
HR
Periodo de tiempo: Perioperative (Heart rate will be recorded at the times when ONSD measurement is performed)

Heart rate (beat/min)

Perioperative (Heart rate will be recorded at the times when ONSD measurement is performed)
etCO2
Periodo de tiempo: Perioperative (End-tidal carbon dioxide levels will be recorded at the times when ONSD measurement is performed)

End-tidal carbon dioxide levels (mmHg)

Perioperative (End-tidal carbon dioxide levels will be recorded at the times when ONSD measurement is performed)

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Airway pressures during mechanical ventilation
Periodo de tiempo: Perioperative (Ppeak, Pplato, Driving pressure (∆P), PEEP levels will be recorded at the times when ONSD measurement is performed)

Ppeak, Pplato, Driving pressure (∆P), PEEP levels (cmH20) will be recorded from the sama ventilation monitor screen

Perioperative (Ppeak, Pplato, Driving pressure (∆P), PEEP levels will be recorded at the times when ONSD measurement is performed)
Postoperative complications
Periodo de tiempo: PONV will be questioned at the 24th hours

Postoperative nause and vomiting (PONV)

PONV will be questioned at the 24th hours
Postoperative complications
Periodo de tiempo: Headache will be questioned at the 24th hours

Headache

Headache will be questioned at the 24th hours
Postoperative complications
Periodo de tiempo: Visual disturbance will be questioned at the 24th hours

Visual disturbance

Visual disturbance will be questioned at the 24th hours

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de diciembre de 2026

Finalización primaria (Estimado)

1 de noviembre de 2027

Finalización del estudio (Estimado)

1 de noviembre de 2027

Fechas de registro del estudio

Enviado por primera vez

3 de noviembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

9 de noviembre de 2026

Publicado por primera vez (Actual)

16 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

16 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

9 de noviembre de 2026

Última verificación

1 de junio de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • E-25403353-050.04-260108454

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .